453 related articles for article (PubMed ID: 12917016)
1. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
Glass DJ; Harper AS
BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
[TBL] [Abstract][Full Text] [Related]
2. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
3. Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine.
Glass D; Harper A
Manag Care Interface; 2004 Feb; 17(2):29-34. PubMed ID: 15038691
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
Spangler DL; Brunton S
South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
Berger WE; Lumry WR; Meltzer EO; Pearlman DS
Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
Prenner BM; Capano D; Harris AG
Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
[TBL] [Abstract][Full Text] [Related]
9. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines.
Greisner WA
Allergy Asthma Proc; 2004; 25(2):81-3. PubMed ID: 15176489
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
12. Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.
Conboy-Ellis K
J Am Acad Nurse Pract; 2005 Aug; 17(8):295-301. PubMed ID: 16045589
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P; Roche N; Faisy C
Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter study of the effectiveness and tolerability of desloratadine in seasonal allergic rhinitis].
Farkas H
Orv Hetil; 2003 May; 144(21):1021-4. PubMed ID: 12847854
[TBL] [Abstract][Full Text] [Related]
17. Diphenhydramine vs desloratadine comparisons must consider risk-benefit ratio.
Blaiss MS
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):121-2. PubMed ID: 16892794
[No Abstract] [Full Text] [Related]
18. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
Van Cauwenberge P; Juniper EF
Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
[TBL] [Abstract][Full Text] [Related]
19. [The place of new antihistamines in allergy management. Apropos of desloratadine].
Sabbah A
Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624
[TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of desloratadine in allergic rhinitis.
González-Núñez V; Valero A; Mullol J
Expert Opin Drug Saf; 2013 May; 12(3):445-53. PubMed ID: 23574541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
